From: eurekalert.org MD Anderson developed a platform to improve both antitumor immune responses and responses to checkpoint inhibitors Researchers at The University of Texas MD Anderson Cancer Center have developed an ultrasound-guided cancer immunotherapy platform that generates systemic antitumor immunity and improves the therapeutic efficacy of immune checkpoint blockade. The findings from the preclinical study were published today in Nature …
-
-
Missing Out By Being Mediocre
-
What I Want Most In My Life
-
I Fired My Friend
-
What Does Memorial Day Mean to You
-
What Birthdays Mean to Me
